Long-term outcomes of ropeginterferon alfa-2b-njft in polycythemia vera: a review of safety, efficacy, and potential disease modification.

Saved in:
Bibliographic Details
Title: Long-term outcomes of ropeginterferon alfa-2b-njft in polycythemia vera: a review of safety, efficacy, and potential disease modification.
Authors: Abu-Zeinah G; Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA., Reeves B; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Source: Leukemia & lymphoma [Leuk Lymphoma] 2026 Jun; Vol. 67 (7), pp. 1492-1501. Date of Electronic Publication: 2026 May 22.
Publication Type: Journal Article; Review
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1029-2403
DOI:10.1080/10428194.2026.2666851